The Effect of Orlistat as an Adjuvant to Lifestyle Modification on Weight Loss in Polycystic Ovary Syndrome Patients:An Evidence-Based Case Report

Nobian Andre, Kevin Aristyo, Aqila Sakina Zhafira, Riesta Hanjani, Diannisa Paramita Susantono, Rachel Ethelind, Listya Tresnanti Mirtha

Research output: Contribution to journalArticlepeer-review

Abstract

Polycystic ovary syndrome (PCOS) occurs in 1 of 10 women of reproductive age. This syndrome is highly associated with obesity. Therefore, many of the patients face weight loss challenges. Given that many patients find it rather difficult to change their lifestyle, medicamentous intervention poses an option. Orlistat is an inhibitor of carboxyl ester lipase which inhibits the hydrolysis of dietary triglycerides that decreases the absorption of fatty acids and monoglyceride. The purpose of this study is to determine whether administration of orlistat can improve diet and exercise-induced body weight reduction in PCOS patients with obesity. Literature searching was done in 3 databases: PubMed, Cochrane Library, and Embase which yielded 141 articles. Findings were narrowed down using duplicate removal, inclusion and exclusion criteria into two relevant articles of randomized controlled trials. One randomized clinical trial showed a greater percentage in weight loss in PCOS patients BMI>23 kg/m2 administered with orlistat and lifestyle modification in comparison to lifestyle modification alone (7.81% (6.51-9.11%) vs 4.7% (4.19-5.21%) ; p25 kg/m2 with orlistat treatment (from 81.5 kg (80.3-82.7) to 76.2 kg (74.92-77.48) vs from 80.91 kg (79.65-82.17) to 79.15 kg (77.8-80.5) ; p<0.01). It was concluded that a considerable reduction of weight in obese and overweight PCOS patients was found when given orlistat with exercise and dietary interventions compared to exercise and dietary interventions alone.
Original languageEnglish
Pages (from-to)15-20
JournalIOSR Journal of Pharmacy
Volume1
Issue number1
Publication statusPublished - 1 Jan 2017

Keywords

  • orlistat, polycystic ovary syndrome, weight loss

Fingerprint Dive into the research topics of 'The Effect of Orlistat as an Adjuvant to Lifestyle Modification on Weight Loss in Polycystic Ovary Syndrome Patients:An Evidence-Based Case Report'. Together they form a unique fingerprint.

Cite this